Sign Up Today and Learn More About Insitro Stock
Invest in or calculate the value of your shares in Insitro or other pre-IPO companies through EquityZen's platform.
Insitro Stock
Insitro is revolutionizing pharmaceutical R&D by leveraging machine learning for drug discovery.
About Insitro Stock
Founded
2018
Headquarters
South San Francisco, CA, US
Industries
Software, Data and Analytics, Science and Engineering
Over the past decades, developing drugs has become increasingly more difficult and expensive, leaving many patients with significant unmet need. A constellation of technologies now allows us to construct, perturb, and observe biological model systems in the laboratory, allowing the generation of biomolecular data at unprecedented breadth and scale. At the same time, the tools of data science and machine learning are now solving problems previously thought to be decades away from solution. We aim to combine these technologies to develop a new approach to drug development that might help us cure more people, sooner, and at a much lower cost.
Insitro Press Mentions
Stay in the know about the latest news on Insitro
Artificial Intelligence for Drug Discovery Market to grow to USD 4.744 Billion by 2032, with an expected CAGR of 15.8%
einpresswire • Jun 10, 2025
Drug Discovery Software Market: Transforming R&D with Innovation in a Rapidly Growing 14% CAGR Sector by 2025
pharmiweb • May 30, 2025
FDA approves Verastem’s ovarian cancer treatment
statnews • May 17, 2025
Vor Bio winding down as multiple biotechs downsize
pharmaphorum • May 16, 2025
Insitro Cuts 22% of Workforce, Extending Runway Into 2027
biospace • May 10, 2025
Investors in Insitro
Discover investors in Insitro stock and explore their portfolio companies
Insitro Management
Leadership team at Insitro
Founder & CEO
Daphne Koller
Join now and verify your accreditation status to gain access to:
- Insitro Current Valuation
- Insitro Stock Price
- Insitro Management
- Available deals in Insitro and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Insitro Cap Table and Funding History by Share Class and Liquidity Preferences
- Insitro Revenue and Financials
- Insitro Highlights
- Insitro Business Model
- Insitro Risk Factors
- Insitro Research Report from SACRA Research
Trading Insitro Stock
How to invest in Insitro stock?
Accredited investors can buy pre-IPO stock in companies like Insitro through EquityZen funds. These investments are made available by existing Insitro shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Insitro stock?
Shareholders can sell their Insitro stock through EquityZen's private company marketplace. EquityZen's network includes over 370K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
